HS
KURA icon

HighVista Strategies’s Kura Oncology KURA Stock Holding History

HighVista Strategies’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-46,181
Closed -$402K – 159
2024
Q4 		$402K Buy
46,181
+25,020
+118% +$360K 0.15% 128
2024
Q3 		$413K Buy
21,161
+4,397
+26% +$89.1K 0.14% 138
2024
Q2 		$345K Buy
+16,764
New +$345K 0.13% 128
2023
Q3 		– Sell
-52,787
Closed -$558K – 152
2023
Q2 		$558K Buy
52,787
+23,545
+81% +$278K 0.26% 116
2023
Q1 		$358K Sell
29,242
-134,871
-82% -$1.68M 0.29% 80
2022
Q4 		$2.04M Sell
164,113
-33,963
-17% -$494K 1.21% 27
2022
Q3 		$2.71M Sell
198,076
-19,819
-9% -$306K 1.55% 24
2022
Q2 		$3.99M Buy
217,895
+70,062
+47% +$1.01M 2.41% 6
2022
Q1 		$2.38M Buy
147,833
+65,709
+80% +$949K 1.51% 19
2021
Q4 		$1.15M Buy
82,124
+11,236
+16% +$182K 0.92% 35
2021
Q3 		$1.33M Buy
70,888
+32,460
+84% +$612K 0.88% 27
2021
Q2 		$801K Buy
38,428
+8,216
+27% +$204K 0.57% 46
2021
Q1 		$854K Buy
30,212
+5,504
+22% +$174K 0.63% 25
2020
Q4 		$807K Sell
24,708
-125
-0.5% -$4.39K 0.52% 45
2020
Q3 		$761K Sell
24,833
-4,908
-17% -$108K 0.55% 18
2020
Q2 		$485K Buy
+29,741
New +$429K 0.4% 26

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighVista Strategies's KURA Position: Q1 2025 in Review

HighVista Strategies sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 46,181 shares — an estimated $402K sold.

HighVista Strategies first reported a position in KURA in Q2 2020 and held it in 16 quarters. The position peaked at $3.99M in Q2 2022. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

  • HighVista Strategies reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
  • HighVista Strategies sold 46,181 Kura Oncology shares in Q1 2025, an estimated $402K.
  • HighVista Strategies first reported a position in Kura Oncology in Q2 2020 and held it in 16 quarters.
  • HighVista Strategies's Kura Oncology position peaked at $3.99M in Q2 2022.
  • 183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on HighVista Strategies's 13F filing for Q1 2025, filed 15 May 2025.